Craft

Vetoquinol

Stock Price

€102.2

2024-02-13

Market Capitalization

€1.2 B

2024-02-13

Revenue

€539.8 M

FY, 2022

Vetoquinol Summary

Company Summary

Overview
Vetoquinol is a veterinary pharmaceutical laboratory. It designs, develops, and sells veterinary drugs and non-medicinal products. The Company offers pain management, anti-infective, cardiology-nephrology, care and hygiene, behavior, internal medicine and reproduction-related products for dogs, cats, cattle, and pigs. 
Type
Public
Status
Active
Founded
1933
HQ
Lure, FR | view all locations
Website
http://www.vetoquinol.com/eng
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Etienne Frechin

    Etienne Frechin, Chairman of the Board

    • Dominique Derveaux

      Dominique Derveaux, Chief Operating Officer

      • Matthieu Frechin

        Matthieu Frechin, CEO, Director

        • Philippe Gruet

          Philippe Gruet, Chief Scientific Officer (CSO)

          LocationsView all

          27 locations detected

          • Lure, Bourgogne-Franche-Comté HQ

            France

            34 Rue du Chêne Sainte-Anne

          • Fort Worth, TX

            United States

            4250 N. Sylvania Ave.

          • Hamilton, QLD

            Australia

            L2/485 Kingsford Smith Dr

          • Wien, Wien

            Austria

            Gußhausstraße 14/5

          • Niel, Vlaams Gewest

            Belgium

            Galileilaan 11/401

          • Aparecida de Goiânia, GO

            Brazil

            Rua 11, Qd. 07, Lts. 47/55, Polo Empresarial Goiás

          and 21 others

          Vetoquinol Financials

          Summary Financials

          Revenue (H1, 2023)
          €256.2M
          Gross profit (H1, 2023)
          €194.3M
          Net income (H1, 2023)
          €32.2M
          Cash (H1, 2023)
          €99.8M
          EBIT (H1, 2023)
          €41.4M
          Enterprise value
          $1.1B

          Footer menu